Familial immune-mediated aplastic anaemia in six different families.

HLA PNH aplastic anaemia bone marrow failure

Journal

EJHaem
ISSN: 2688-6146
Titre abrégé: EJHaem
Pays: United States
ID NLM: 101761942

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 28 01 2023
revised: 16 04 2023
accepted: 15 05 2023
medline: 21 8 2023
pubmed: 21 8 2023
entrez: 21 8 2023
Statut: epublish

Résumé

We studied the pathophysiology of aplastic anaemia (AA) in six different pairs of relatives without a family history of hematologic disorders or congenital AA. Five and four of the six pairs shared the

Identifiants

pubmed: 37601868
doi: 10.1002/jha2.722
pii: JHA2722
pmc: PMC10435714
doi:

Types de publication

Journal Article

Langues

eng

Pagination

714-718

Informations de copyright

© 2023 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest associated with this study. The funders had no role in the study design, data collection and analysis, decision to publish or manuscript preparation.

Références

Blood. 2017 May 25;129(21):2908-2916
pubmed: 28232583
Blood. 2011 Dec 15;118(25):6601-9
pubmed: 21963603
JCI Insight. 2020 Jul 9;5(13):
pubmed: 32641579
J Clin Invest. 2001 Sep;108(5):765-73
pubmed: 11544283
Exp Hematol. 2007 Jan;35(1):13-20
pubmed: 17198869
Cell Rep. 2020 Oct 20;33(3):108297
pubmed: 33086059
Immunity. 2015 Oct 20;43(4):647-59
pubmed: 26474655
Blood. 2013 Nov 28;122(23):3844-5
pubmed: 24288411
Blood. 2001 Dec 15;98(13):3513-9
pubmed: 11739151
Blood Adv. 2017 Oct 10;1(22):1900-1910
pubmed: 28971166
J Allergy Clin Immunol. 2015 Dec;136(6):1619-1626.e5
pubmed: 26220525
Br J Haematol. 2016 Jan;172(1):131-4
pubmed: 25929998
Blood. 2018 Feb 15;131(7):717-732
pubmed: 29146883
Cell Death Dis. 2016 Jun 09;7(6):e2260
pubmed: 27277682
Exp Hematol. 2016 Oct;44(10):931-939.e3
pubmed: 27250585

Auteurs

Tatsuya Imi (T)

Department of Hematology Graduate School of Medical Sciences Kanazawa University Kanazawa Japan.

Hiroki Mizumaki (H)

Department of Hematology Graduate School of Medical Sciences Kanazawa University Kanazawa Japan.

Kazuyoshi Hosomichi (K)

Department of Bioinformatics and Genomics Graduate School of Advanced Preventive Medical Sciences Kanazawa University Kanazawa Japan.

Yasuhito Nannya (Y)

Pathology and Tumor Biology Graduate School of Medicine Kyoto University Kyoto Japan.
Division of Hematopoietic Disease Control Institute of Medical Sciecen The University of Tokyo Tokyo Japan.

Yoshitaka Zaimoku (Y)

Department of Hematology Graduate School of Medical Sciences Kanazawa University Kanazawa Japan.

Takeshi Yoroidaka (T)

Department of Hematology Graduate School of Medical Sciences Kanazawa University Kanazawa Japan.

Takamasa Katagiri (T)

Department of Clinical Laboratory Sciences Graduate School of Medical Sciences Kanazawa University Kanazawa Japan.

Ken Ishiyama (K)

Department of Hematology Graduate School of Medical Sciences Kanazawa University Kanazawa Japan.

Hirohito Yamazaki (H)

Department of Hematology Graduate School of Medical Sciences Kanazawa University Kanazawa Japan.

Ryosuke Ogawa (R)

Department of Hematology and Oncology Japan Community Health Care Organization Kyushu Hospital Fukuoka Japan.

Mika Kuroiwa (M)

Department of Hematology and Oncology National Hospital Organization Fukuoka Higashi Medical Center Fukuoka Japan.

Atsushi Tajima (A)

Department of Bioinformatics and Genomics Graduate School of Advanced Preventive Medical Sciences Kanazawa University Kanazawa Japan.

Seishi Ogawa (S)

Pathology and Tumor Biology Graduate School of Medicine Kyoto University Kyoto Japan.

Shinji Nakao (S)

Department of Hematology Graduate School of Medical Sciences Kanazawa University Kanazawa Japan.

Classifications MeSH